Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5533092
[patent_doc_number] => 20090232880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Analogue Compounds Of Archaebacterial Membrane Lipids And Liposomal Compounds Integrating Such Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/792011
[patent_app_country] => US
[patent_app_date] => 2005-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4956
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232880.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792011
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792011 | Analogue compounds of archaebacterial membrane lipids and liposomal compounds integrating such compounds | Dec 6, 2005 | Issued |
Array
(
[id] => 5843210
[patent_doc_number] => 20060121512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Biological pathways in progenitor cells'
[patent_app_type] => utility
[patent_app_number] => 11/292147
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10047
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121512.pdf
[firstpage_image] =>[orig_patent_app_number] => 11292147
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/292147 | Biological pathways in progenitor cells | Dec 1, 2005 | Abandoned |
Array
(
[id] => 4982424
[patent_doc_number] => 20070086982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Gene therapy for regulating smooth muscle tone'
[patent_app_type] => utility
[patent_app_number] => 11/291481
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 23154
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20070086982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11291481
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/291481 | Gene therapy for regulating smooth muscle tone | Nov 30, 2005 | Abandoned |
Array
(
[id] => 7523067
[patent_doc_number] => 08026223
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-09-27
[patent_title] => 'Treating malignant tumors with high field strength electroporation of plasmids encoding IL-12'
[patent_app_type] => utility
[patent_app_number] => 11/164626
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8696
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/026/08026223.pdf
[firstpage_image] =>[orig_patent_app_number] => 11164626
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/164626 | Treating malignant tumors with high field strength electroporation of plasmids encoding IL-12 | Nov 29, 2005 | Issued |
Array
(
[id] => 8527613
[patent_doc_number] => 08304183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-06
[patent_title] => 'Selective terminal tagging of nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 12/095409
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 21638
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12095409
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095409 | Selective terminal tagging of nucleic acids | Nov 29, 2005 | Issued |
Array
(
[id] => 5715628
[patent_doc_number] => 20060078991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Antibody composition-producing cell'
[patent_app_type] => utility
[patent_app_number] => 11/287359
[patent_app_country] => US
[patent_app_date] => 2005-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 77447
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20060078991.pdf
[firstpage_image] =>[orig_patent_app_number] => 11287359
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/287359 | Antibody composition-producing cell | Nov 27, 2005 | Issued |
Array
(
[id] => 836868
[patent_doc_number] => 07393683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-01
[patent_title] => 'Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase'
[patent_app_type] => utility
[patent_app_number] => 11/287324
[patent_app_country] => US
[patent_app_date] => 2005-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 74
[patent_no_of_words] => 77445
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/393/07393683.pdf
[firstpage_image] =>[orig_patent_app_number] => 11287324
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/287324 | Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase | Nov 27, 2005 | Issued |
Array
(
[id] => 5913807
[patent_doc_number] => 20060128814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Photolytic cross-linkable monomers'
[patent_app_type] => utility
[patent_app_number] => 11/281524
[patent_app_country] => US
[patent_app_date] => 2005-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4984
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128814.pdf
[firstpage_image] =>[orig_patent_app_number] => 11281524
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/281524 | Photolytic cross-linkable monomers | Nov 16, 2005 | Abandoned |
Array
(
[id] => 5198776
[patent_doc_number] => 20070298094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Medicinal Composition, Preparation and Combined Preparation'
[patent_app_type] => utility
[patent_app_number] => 11/667954
[patent_app_country] => US
[patent_app_date] => 2005-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16280
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20070298094.pdf
[firstpage_image] =>[orig_patent_app_number] => 11667954
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/667954 | Medicinal Composition, Preparation and Combined Preparation | Nov 15, 2005 | Abandoned |
Array
(
[id] => 5428096
[patent_doc_number] => 20090087406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'REVERSE MICELLES BASED ON PHYTOSTEROLS AND ACYLGLYCEROLS AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/718513
[patent_app_country] => US
[patent_app_date] => 2005-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6996
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20090087406.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718513
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718513 | Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof | Nov 1, 2005 | Issued |
Array
(
[id] => 8213904
[patent_doc_number] => 08192988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'Methods for increasing potency of adult mesenchymal stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/258401
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 17
[patent_no_of_words] => 8300
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/192/08192988.pdf
[firstpage_image] =>[orig_patent_app_number] => 11258401
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/258401 | Methods for increasing potency of adult mesenchymal stem cells | Oct 23, 2005 | Issued |
Array
(
[id] => 5814840
[patent_doc_number] => 20060084622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Angiogenic factor and use thereof in treating cardiovascular disease'
[patent_app_type] => utility
[patent_app_number] => 11/254675
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17984
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084622.pdf
[firstpage_image] =>[orig_patent_app_number] => 11254675
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/254675 | Angiogenic factor and use thereof in treating cardiovascular disease | Oct 20, 2005 | Abandoned |
Array
(
[id] => 5726954
[patent_doc_number] => 20060057714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Vector'
[patent_app_type] => utility
[patent_app_number] => 11/252063
[patent_app_country] => US
[patent_app_date] => 2005-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5306
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057714.pdf
[firstpage_image] =>[orig_patent_app_number] => 11252063
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/252063 | Vector | Oct 17, 2005 | Issued |
Array
(
[id] => 5464498
[patent_doc_number] => 20090324698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'LIPOSOMAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT FOR RELAXING SMOOTH MUSCLE, THE PRODUCTION OF THIS COMPOSITION AND THE THERAPEUTIC USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/577488
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3605
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324698.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577488
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577488 | Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and the therapeutic use thereof | Oct 13, 2005 | Issued |
Array
(
[id] => 5881457
[patent_doc_number] => 20060030540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent'
[patent_app_type] => utility
[patent_app_number] => 11/244782
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 13770
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20060030540.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244782 | Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent | Oct 5, 2005 | Abandoned |
Array
(
[id] => 5830903
[patent_doc_number] => 20060064781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Antibody composition-producing cell'
[patent_app_type] => utility
[patent_app_number] => 11/240579
[patent_app_country] => US
[patent_app_date] => 2005-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 77425
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20060064781.pdf
[firstpage_image] =>[orig_patent_app_number] => 11240579
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/240579 | Antibody composition-producing cell | Oct 2, 2005 | Abandoned |
Array
(
[id] => 10039068
[patent_doc_number] => 09079765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Nanoparticles comprising antigens and adjuvants, and immunogenic structures'
[patent_app_type] => utility
[patent_app_number] => 11/576415
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 13368
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11576415
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576415 | Nanoparticles comprising antigens and adjuvants, and immunogenic structures | Sep 29, 2005 | Issued |
Array
(
[id] => 5638081
[patent_doc_number] => 20060069055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Delivery of polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/233511
[patent_app_country] => US
[patent_app_date] => 2005-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 39548
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069055.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233511
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233511 | Delivery of polynucleotides | Sep 20, 2005 | Abandoned |
Array
(
[id] => 80782
[patent_doc_number] => 07744920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Use of liposomal glucocorticoids for treating inflammatory states'
[patent_app_type] => utility
[patent_app_number] => 11/662174
[patent_app_country] => US
[patent_app_date] => 2005-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 12808
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/744/07744920.pdf
[firstpage_image] =>[orig_patent_app_number] => 11662174
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/662174 | Use of liposomal glucocorticoids for treating inflammatory states | Sep 10, 2005 | Issued |
Array
(
[id] => 5828206
[patent_doc_number] => 20060063254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Antibody composition-producing cell'
[patent_app_type] => utility
[patent_app_number] => 11/218473
[patent_app_country] => US
[patent_app_date] => 2005-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 77392
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063254.pdf
[firstpage_image] =>[orig_patent_app_number] => 11218473
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/218473 | Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation | Sep 5, 2005 | Issued |